[1]阎明, 孟繁立, 肝硬化肝肾综合征的治疗[J], 中华肝脏病杂志, 2005, 13 (6) :458.
|
[2]Salerno F, Gerbes A, Gines P, et al.Diagnosis, preventionand treatment of hepatorenal syndrome in cirrhosis[J].Gut, 2007, 56 (9) :1310-1318
|
[3]梁汝忠, 梁月连, 杨彬.肝肾综合征并发电解质和酸碱失衡的临床研究[J]、实用医技杂志, 2005, 12 (4) :915-917
|
[4]韦志明.肝肾综合征发病机制及药物治疗进展[J].华夏医学, 2008, 21 (4) :842-844.
|
[5]Wong F, Blendis L.New challenge of hepatorenalsyndrome:prevention and treatment[J].Hepatology, 2001, 34 (6) :1242.
|
[6]ArroyoV, Guevara M, Gines P.Hepatorenal syndromein cirrhosis pathogenesis and treatment[J].Gastroenterology, 2002, 122 (8) :1658-1676.
|
[7]刘金旭, 陈文梅, 肝肾综合征的研究进展[J], 实用肝病杂志, 2008, 12 (6) :426-428.
|
[8]周晓琳, 覃慧敏, 谢迎春, 等.肝硬化腹腔积液并发肝肾综合征的高危因素探讨[J].中国综合临床杂志, 2007, 6 (23) :508-510.
|
[9]刘芳, 何维新, 谢娟, 等, 肝肾综合征诊治现状[J].中华肝脏病杂志, 2003, 11 (10) :638.
|
[10]秦向荣.生长抑素治疗I型肝肾综合征的疗效观察[J].药学与临床研究, 2007, 15 (6) :470-471.
|
[11]Fabrizi F, Dixit V, Martin P.Meta-analysis:terlipressintherapy for the hepatorenal syndrome[J].AlimentPharmacol Ther, 2006, 24 (6) :935-944.
|
[12]陈炎, 陈亚蓓, 陶荣芳.全腹腔穿刺放液对肝硬化门静脉血流动力学的影响[J].中国实用内科杂志, 2004, 24 (8) :473-475.
|
[13]胡哨兵, 杨湛, 唐小平, 等.分子吸附循环系统治疗慢性重症肝炎患者预后的改善[J].中华肝脏病杂志, 2003, 11 (10) :629-630.
|
[14]Paolo Angeli, Carlo merkel.Pathogenesis and ma-nagenment of hepatorenal syndrome in patients withcirrhosis[J].J Hepatology, 2008, 48 (Suppl 1) :S93-S103.
|